Literature DB >> 7972130

Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.

C Sakakura1, Y Yamaguchi-Iwai, M Satake, S C Bae, A Takahashi, E Ogawa, A Hagiwara, T Takahashi, A Murakami, K Makino.   

Abstract

The translocation from chromosome 8 to chromosome 21, t(8;21), associated with acute myeloid leukemia results in production of an AML1/MTG8(ETO) fusion transcript. The product of the AML1 gene contains an evolutionarily conserved 128-amino acid region referred to as the "Runt domain," which is necessary for binding to DNA at the PEBP2 site. A fragment of the AML1 protein containing mainly the Runt domain and the antisense oligonucleotide complementary to the fusion transcript strongly inhibited the growth and induced differentiation of cell lines derived from acute myeloid leukemia containing t(8;21). These results indicate that the transcriptional regulation through the PEBP2 site is critically important for growth and differentiation of t(8;21) leukemic cells and that the product of the chimeric gene is responsible for the maintenance of the leukemic phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972130      PMCID: PMC45304          DOI: 10.1073/pnas.91.24.11723

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer.

Authors:  Y Kamachi; E Ogawa; M Asano; S Ishida; Y Murakami; M Satake; Y Ito; K Shigesada
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene.

Authors:  M Satake; T Ibaraki; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

5.  Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.

Authors:  J D Rowley
Journal:  Ann Genet       Date:  1973-06

6.  Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

Review 7.  The Runt domain identifies a new family of heteromeric transcriptional regulators.

Authors:  H Kagoshima; K Shigesada; M Satake; Y Ito; H Miyoshi; M Ohki; M Pepling; P Gergen
Journal:  Trends Genet       Date:  1993-10       Impact factor: 11.639

8.  Acute leukaemia in bcr/abl transgenic mice.

Authors:  N Heisterkamp; G Jenster; J ten Hoeve; D Zovich; P K Pattengale; J Groffen
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

9.  PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

Authors:  S C Bae; E Ogawa; M Maruyama; H Oka; M Satake; K Shigesada; N A Jenkins; D J Gilbert; N G Copeland; Y Ito
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  24 in total

1.  Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides.

Authors:  J A Toretsky; Y Connell; L Neckers; N K Bhat
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.

Authors:  Y Kanno; T Kanno; C Sakakura; S C Bae; Y Ito
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.

Authors:  Y W Zhang; S C Bae; G Huang; Y X Fu; J Lu; M Y Ahn; Y Kanno; T Kanno; Y Ito
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

Authors:  M Y Ahn; G Huang; S C Bae; H J Wee; W Y Kim; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 5.  Structural alterations in the transcription factor PEBP2/CBF linked to four different types of leukemia.

Authors:  Y Ito
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF.

Authors:  J Lu; M Maruyama; M Satake; S C Bae; E Ogawa; H Kagoshima; K Shigesada; Y Ito
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

7.  Transcriptional diversity during monocyte to macrophage differentiation.

Authors:  Hongtao Liu; Bo Shi; Chiang-Ching Huang; Polikseni Eksarko; Richard M Pope
Journal:  Immunol Lett       Date:  2008-01-22       Impact factor: 3.685

8.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation.

Authors:  S Meyers; N Lenny; S W Hiebert
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

9.  p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death.

Authors:  Ondrej Krejci; Mark Wunderlich; Hartmut Geiger; Fu-Sheng Chou; David Schleimer; Michael Jansen; Paul R Andreassen; James C Mulloy
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

10.  Identification of AML1-ETO modulators by chemical genomics.

Authors:  Steven M Corsello; Giovanni Roti; Kenneth N Ross; Kwan T Chow; Ilene Galinsky; Daniel J DeAngelo; Richard M Stone; Andrew L Kung; Todd R Golub; Kimberly Stegmaier
Journal:  Blood       Date:  2009-04-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.